Q4 2011

Source filing unavailable

Q4 2011 · —

Revenue—

Net Income

$152.00K

no prior Q4 2010 on file

EPS Diluted

$0.00

no prior Q4 2010 on file

Gross Profit$5,833,000—

Operating Incomederived$374,000—

Operating Cash Flow

Same quarter

Metric	Q4 2011	Q4 2010derived from reported figures
Net Income	$152.00K	—
EPS Diluted	$0.00	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR